...

首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Evaluation of the Impact of Anti-Thymocyte Globulin (ATG) on Post-Hematopoietic Cell Transplant (HCT) Outcomes in Patients Undergoing Allogeneic HCT

【24h】

Evaluation of the Impact of Anti-Thymocyte Globulin (ATG) on Post-Hematopoietic Cell Transplant (HCT) Outcomes in Patients Undergoing Allogeneic HCT

机译：异基因HCT患者抗胸腺细胞球蛋白（ATG）对造血后细胞移植（HCT）结果的影响评估

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2015年第1期|共2页
作者
Kaminski Katie S.; Beechinor Ryan; Lebovic Rachel; Roth Mary; Bangdiwala Ananta; Ballarini Nicolas; Ivanova Anastasia; Chong Pearlie P.; Jamieson Katarzyna; Shea Thomas C.; Rao Kamakshi V.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. 移植物抗宿主病对26例血液肿瘤患者异基因造血干细胞移植后长期生存的影响 [J] . 林曲, 董敏, 汪清铭, 癌症（英文版） . 2006,第010期
2. Evaluation of the Impact of Anti-Thymocyte Globulin (ATG) on Post-Hematopoietic Cell Transplant (HCT) Outcomes in Patients Undergoing Allogeneic HCT [J] . Kaminski Katie S., Beechinor Ryan, Lebovic Rachel, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第2Suppla1期

机译：异基因HCT患者抗胸腺细胞球蛋白（ATG）对造血后细胞移植（HCT）结果的影响评估
3. Empiric Anti-Thymocyte Globulin (ATG) Dosing in Ex-Vivo CD34-Selected Myeloablative Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) May Result in ATG Overexposure That Negatively Affects Outcomes [J] . Michael Scordo, Valkal Bhatt, Melody Smith, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：在ex-Vivo CD34 - 选择的霉菌化同种异体造血细胞移植（Allo-HCT）中给药的经验抗胸腺细胞球蛋白（ATG）可能导致ATG过度影响结果产生负面影响
4. Impact of comorbidities constituting the hematopoietic cell transplant (HCT)‐comorbidity index on the outcome of patients undergoing allogeneic HCT for acute myeloid leukemia [J] . Khalil Manar M. I., Lipton Jeffrey H., Atenafu Eshetu G., European Journal of Haematology . 2018,第Suppla1期

机译：构成造血细胞移植（HCT） - 功能性指数对急性髓性白血病对同种异体HCT患者的结果的影响
5. THE EFFECT OF INHIBITORY KILLER-CELL IG-LIKE RECEPTOR (IKIR) MATCHING IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) [C] . David Senitzer, Joel Y. Sun, Arisa Oki, Clinical Histocompatibility Workshop. . 2009

机译：同种异体造血细胞移植（HCT）中抑制杀伤细胞IG样受体（IKIR）匹配的影响
6. A Retrospective Analysis of Renal Transplant Outcomes: induction Immunosuppression with Anti-thymocyte Globulin vs. Alemtuzumab in patients undergoing Deceased and Living Donor Kidney Transplantation. [D] . DiMartino, Debra A. 2012

机译：肾移植结果的回顾性分析：死者和活体供者肾脏移植患者中抗胸腺细胞球蛋白与Alemtuzumab的诱导免疫抑制作用。
7. Clinical impact of anti-thymocyte globulin on survival and graft-versus-host disease in patients undergoing human leukocyte antigen mismatched allogeneic stem cell transplantation [O] . Taeyun Kim, Yunsuk Choi, Je-Hwan Lee, 2020

机译：抗胸腺细胞球蛋白对人白细胞抗原错配同种异体干细胞移植患者生存和移植物抗宿主病的临床影响
8. Evaluation of the Impact of Anti-Thymocyte Globulin (ATG) on Post-Hematopoietic Cell Transplant (HCT) Outcomes in Patients Undergoing Allogeneic HCT [O] . Kaminski Katie S., Beechinor Ryan, Lebovic Rachel, 2015

机译：异基因HCT患者抗胸腺细胞球蛋白（ATG）对造血后细胞移植（HCT）结果的影响评估

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号